Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novadoz Pharmaceuticals, a wholly owned US affiliate of MSN Laboratories (India), is a commercial-stage generics company marketing FDA-approved oral solids, oral solutions, and injectables with multiple approved ANDAs and an actively expanding pipeline. Products in the US market include generics for albendazole, droxidopa, deferasirox, pregabalin ER, rosuvastatin, moxifloxacin, and capecitabine, spanning anti-infective, cardiovascular, CNS, and oncology indications. Recent launches include 'Made in the USA' oral solutions from its Piscataway, NJ manufacturing facility, with 20–25 ANDA filings targeted per year and substantial vertical integration with its API parent. The pipeline is diversified and commercial.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novadoz Pharmaceuticals.